Last reviewed · How we verify
NCT04344106: ProCov
Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study
NA trial testing Prone positioning in Coronavirus Infection in 25 participants. Status unknown.
15 April 2020
Quick facts
| Lead sponsor | ELHARRAR Xavier |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 25 |
| Start date | 1 April 2020 |
| Primary completion | 15 April 2020 |
| Estimated completion | 1 May 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Prone positioning
Conditions studied
- Coronavirus Infection — all drugs for Coronavirus Infection →
- Oxygen Deficiency — all drugs for Oxygen Deficiency →
Sponsor
ELHARRAR Xavier
Who can join
18 and older, any sex, with Coronavirus Infection or Oxygen Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The prone position consists of placing the patient on his or her stomach with the head on the side, during sessions lasting several hours a day and could help spontaneous ventilate the patient.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Awake Proning: Current Evidence and Practical Considerations.
Sodhi K, Chanchalani G. · · 2020 · cited 12× · PMID 33446979 · DOI 10.5005/jp-journals-10071-23684 -
Prone position ventilation in non-intubated, spontaneously ventilating patients: New guidance from the Intensive Care Society (UK) and existing evidence.
Purvis P, Francis O. · · 2023 · cited 1× · PMID 37928087 · DOI 10.1177/1751143720930604
Verify or expand the search:
- PubMed search for NCT04344106
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Prone positioning
Trials testing the same drug.
- NCT04012073 — Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress S · Phase 3 · terminated
- NCT05002478 — Infants with Severe Acute Respiratory Distress Syndrome: the Prone Trial · NA · recruiting
- NCT05092737 — Physiological Response to Prone Position in COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) · completed
- NCT06493058 — Extruded the effectıveness of Prone posıtıon ın ınfants evaluatıon · NA · completed
- NCT06517745 — Effect of Prone Positionning in Non Intubated Patients · completed
Other recruiting trials for Coronavirus Infection
Currently open trials in the same condition.
- NCT04885504 — Post COVID-19 Biorepository · recruiting
- NCT04445454 — Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection · Phase 1, PHASE2 · recruiting
- NCT04510025 — Capturing MultiORgan Effects of COVID-19 · recruiting
- NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04344106 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ELHARRAR Xavier
- Last refreshed: 14 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04344106.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing